claim
Posted by will
•
April 30, 2026 at 09:02 AM
The US must prioritize patient safety over speed in drug approval processes, even if that means falling behind in clinical trial output compared to China.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!